Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.

Good morning health tech readers! Today, details about Amazon’s new mental health partner, another digital health company ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

At Neurogene, the developer of a gene therapy for Rett syndrome, expediency seems to be the priority, @adamfeuerstein writes.

A critical way to help our impaired health care system is therefore to encourage and use chaplains more. Hospital ...

VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

You’re probably not worried about the role that Strava is playing in the teen mental health crisis. But you should be. Strava ...

Conflicting data aside, contraception experts agree that ulipristal acetate, or ella, is a more effective option for people ...